HER2-positive breast cancer: What is it?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - April 9, 2024 Category: Consumer Health News Source Type: news
Gland Pharma gets USFDA nod for generic breast cancer drug
Gland Pharma has received approval from the USFDA to market a generic medication for breast cancer treatment, Eribulin Mesylate Injection. It's expected to be the first generic approval in the market, with sales of around USD 92 million in the US. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 8, 2024 Category: Pharmaceuticals Source Type: news
Why Heart Disease Research Still Favors Men
Published in partnership with The Fuller Project, a nonprofit newsroom dedicated to the coverage of women’s issues around the world.
Katherine Fitzgerald had just arrived at the party. Before she could even get a drink, she threw up and broke out in a sweat. “I was dizzy. I couldn’t breathe. I had heart pain,” Fitzgerald says.
She knew she was having a heart attack.
[time-brightcove not-tgx=”true”]
What she didn’t know then was that the heart attack could have been prevented. Fitzgerald, a health-conscious, exercise-loving lawyer, should have been taking statin drugs to s...
Source: TIME: Health - April 5, 2024 Category: Consumer Health News Authors: Maggie Fox Tags: Uncategorized freelance healthscienceclimate Source Type: news
Dartmouth event bats around promise, shortcomings of AI in healthcare
Dartmouth's Center for Precision Health and Artificial Intelligence held its first symposium April 3 featuring leaders from radiology, pathology, and more.
A keynote delivered by Curtis Langlotz, MD, PhD, professor of radiology, medicine, and biomedical data science at Stanford University, summarized that AI algorithms can assist radiologists at every step of the imaging process.
"There are aids that can provide inputs to help decide which imaging tests to order; programs to enhance image quality, making it possible to reduce radiation doses used in imaging; tools that instantaneously detect imaging problems to ensure t...
Source: AuntMinnie.com Headlines - April 5, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Practice Management Imaging Informatics Industry News Source Type: news
Omission of Completion Axillary-Lymph-Node Dissection Noninferior
THURSDAY, April 4, 2024 -- For patients with clinically node-negative breast cancer with sentinel-node macrometastases, the omission of completion axillary-lymph-node dissection is noninferior to more extensive surgery, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 4, 2024 Category: Pharmaceuticals Source Type: news
9 ways to ease the radiologist workforce shortage
Radiology is experiencing a workforce shortage, but there are at least 9 ways to mitigate it, according to a clinical perspective published April 3 in the American Journal of Roentgenology.
Lead author James Rawson, MD, of Beth Israel Medical Center in Boston and colleagues noted that, as the "current radiology landscape has an imbalance between the rising demand for radiology services and the national radiologist workforce available," it's crucial to implement creative strategies to address the workforce shortage issue.
"Rather than working longer and/or faster, there are ways for radiologists to work smarter," it noted...
Source: AuntMinnie.com Headlines - April 4, 2024 Category: Radiology Authors: Kate Madden Yee Tags: Practice Management Source Type: news
Evidence Strengthens for De-Escalating Axillary Surgery in Breast Cancer
(MedPage Today) -- The concept of skipping axillary lymph node dissection (ALND) in some patients with breast cancer was supported by a European noninferiority trial.
Among patients with early-stage, node-negative breast cancer and one or two... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 3, 2024 Category: Hematology Source Type: news
Victim of America's 'CANCER COLLEGE': Widower reveals how late wife, 35, was diagnosed with terminal breast tumors while pregnant with her son - and died before seeing him grow up... as family blame 'toxic' North Carolina university building
Sarah Glad, from South Carolina, was diagnosed with stage four triple negative breast cancer almost ten years after studying at North Carolina State's 'toxic' Poe Hall. (Source: the Mail online | Health)
Source: the Mail online | Health - April 3, 2024 Category: Consumer Health News Source Type: news
Hormonal Birth Control Doesn ’ t Deserve Its Bad Reputation
Almost two-thirds of U.S. women of reproductive age use some kind of contraception, according to the latest federal data. And millions of them use methods that contain hormones, including birth control pills, intrauterine devices (IUDs), rings, implants, injections, and patches.
Although the specifics vary from method to method, hormonal birth control generally works by halting ovulation and/or changing conditions in the uterus or cervix to prevent pregnancy. And it works well: efficacy rates approach 100% when these methods are used correctly.
[time-brightcove not-tgx=”true”]
But hormonal birth control ...
Source: TIME: Health - April 3, 2024 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Evergreen Explainer healthscienceclimate Source Type: news
Polygenic Risk Scores Improve Breast Cancer Screening Polygenic Risk Scores Improve Breast Cancer Screening
A Finnish study shows that adding polygenic risk scores to positive family histories and breast cancer-associated gene mutations improves risk stratification for breast cancer screening.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 3, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Test Might Allow Some Patients With Aggressive Breast Cancer Skip Chemo
WEDNESDAY, April 3, 2024 -- A new test might allow some women with an aggressive form of breast cancer to skip chemotherapy without harm, researchers say.Women with early-stage triple-negative breast cancer appear to have better survival rates and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 3, 2024 Category: General Medicine Source Type: news
More Evidence Ties Tumor Infiltrating Lymphocytes to TNBC Outcomes
(MedPage Today) -- Higher levels of tumor infiltrating lymphocytes (TILs) in triple-negative breast cancer (TNBC) not treated with systemic therapy correlated with significantly better survival, according to a retrospective study of an international... (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - April 2, 2024 Category: OBGYN Source Type: news
SBI president previews annual symposium
Attendees have much to experience and take away from the Society of Breast Imaging (SBI) annual symposium, according to society president Mimi Newell, MD.
The symposium will be held April 11 to 14 in Montreal, Quebec, Canada, and will feature the latest research and insights from breast imaging experts and vendors.
“I think our attendees are going to learn a ton, but also have a lot of fun, which is important in this kind of situation,” Newell told AuntMinnie.com.
The annual meeting aims to strengthen knowledge and skills for breast imagers, including improving interpretative accuracy along imaging modalities, apply...
Source: AuntMinnie.com Headlines - April 2, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Womens Imaging Imaging Leaders Source Type: news
Datopotamab Deruxtecan Biologics License Application Accepted in the US for Patients with Previously Treated Metastatic HR-Positive, HER2-Negative Breast Cancer
2 April 2024 -- AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US for the treatment of adult patients with unresectable or metastatic hormone receptor... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 2, 2024 Category: Drugs & Pharmacology Source Type: news
New study finds triple-negative breast cancer tumors with an increase in immune cells have lower risk of recurrence after surgery
ROCHESTER, Minn. — A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not treated with chemotherapy. The study was published today in the Journal of American Medical Association (JAMA). TNBC is a breast cancer subtype that does not respond to drugs that target the estrogen receptor or… (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - April 2, 2024 Category: Research Source Type: news
